Deva Holding AS (IS:DEVA) — Market Cap & Net Worth
Market Cap & Net Worth: Deva Holding AS (DEVA)
Deva Holding AS (IS:DEVA) has a market capitalization of $302.62 Million (TL13.51 Billion) as of June 16, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #14920 globally and #152 in its home market, demonstrating a 3.37% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Deva Holding AS's stock price TL67.55 by its total outstanding shares 200019288 (200.02 Million). Review DEVA total liabilities to assess the company's total debt and financial obligations.
Deva Holding AS Market Cap History: 2015 to 2026
Deva Holding AS's market capitalization history from 2015 to 2026. Data shows growth from $17.01 Million to $302.62 Million (31.55% CAGR).
Deva Holding AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Deva Holding AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Deva Holding AS's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.06x
Deva Holding AS's market cap is 5.06 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $17.01 Million | $576.38 Million | $47.66 Million | 0.03x | 0.36x |
| 2016 | $15.43 Million | $688.46 Million | $60.33 Million | 0.02x | 0.26x |
| 2017 | $19.20 Million | $800.30 Million | $92.54 Million | 0.02x | 0.21x |
| 2018 | $14.42 Million | $1.04 Billion | $136.36 Million | 0.01x | 0.11x |
| 2019 | $39.40 Million | $1.37 Billion | $286.02 Million | 0.03x | 0.14x |
| 2020 | $106.55 Million | $1.86 Billion | $651.45 Million | 0.06x | 0.16x |
| 2021 | $127.28 Million | $2.33 Billion | $1.17 Billion | 0.05x | 0.11x |
| 2022 | $307.92 Million | $4.48 Billion | $1.36 Billion | 0.07x | 0.23x |
| 2023 | $337.44 Million | $16.36 Billion | $4.89 Billion | 0.02x | 0.07x |
| 2024 | $351.23 Million | $15.46 Billion | $69.42 Million | 0.02x | 5.06x |
Competitor Companies of DEVA by Market Capitalization
Companies near Deva Holding AS in the global market cap rankings as of June 16, 2026.
Key companies related to Deva Holding AS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #512 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #613 globally with a market cap of $44.69 Billion USD ( CN¥305.43 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #629 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #512 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.41 |
| #613 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.69 Billion | CN¥47.88 |
| #629 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Deva Holding AS Historical Marketcap From 2015 to 2026
Between 2015 and today, Deva Holding AS's market cap moved from $17.01 Million to $ 302.62 Million, with a yearly change of 31.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL302.62 Million | +7.74% |
| 2025 | TL280.89 Million | -20.03% |
| 2024 | TL351.23 Million | +4.08% |
| 2023 | TL337.44 Million | +9.59% |
| 2022 | TL307.92 Million | +141.92% |
| 2021 | TL127.28 Million | +19.46% |
| 2020 | TL106.55 Million | +170.39% |
| 2019 | TL39.40 Million | +173.25% |
| 2018 | TL14.42 Million | -24.89% |
| 2017 | TL19.20 Million | +24.43% |
| 2016 | TL15.43 Million | -9.28% |
| 2015 | TL17.01 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Deva Holding AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $302.62 Million USD |
| MoneyControl | $302.62 Million USD |
| MarketWatch | $302.62 Million USD |
| marketcap.company | $302.62 Million USD |
| Reuters | $302.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more